S.2295 - Patient Safety and Generic Labeling Improvement Act
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. view all titles (2)
All Bill Titles
- Official: A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. as introduced.
- Short: Patient Safety and Generic Labeling Improvement Act as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 2
- Past Seven Days: 13
- All-Time: 1,131
|
|
|
|
|
|
|
|
Official Summary
4/18/2012--Introduced.Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorizedOfficial Summary
4/18/2012--Introduced.Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application. Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug....Read the Rest
Organizations Supporting S.2295
- American Association for Justice
- Public Citizen
- Baum, Hedlund, Aristei & Goldman, PC
- American Association of Retired Persons
- Alliance for Justice
- Consumer Action
- ...and 6 more. See all.
Organizations Opposing S.2295
- Generic Pharmaceutical Association

U.S. Congress - S.2295 Patient Safety and Generic Labeling Improvement Act



